Skip to main content
OpenTrials
Completed

NCT Number: NCT01562665

Epidemiological Study to Describe Non Small Cell Lung Cancer Clinical Management Patterns in MENA. Lung-EPICLIN/ Gulf

The overall aim of the study is:

To provide accurate and reliable information regarding NSCLC clinical management across MENA region in order to detect unmet medical needs of this disease in terms of:

* Patient and hospital characteristics. * Diagnostic and treatment approaches: initial and subsequent. * Follow-up patterns in clinical management. * Outcomes: symptoms, death, functionality, quality of life. * Use of resources and burden on patients and health care systems.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Non Small Cells Lung Cancer

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Manama, Bahrain

Loading trial locations.

About this study

Epidemiological study to describe NSCLC clinical management patterns in MENA

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Confirmed NSCLC diagnosis (e.g. bronchoscope or FNAB), all stages, men and women, attending the responsible department of treating this type of patients for the first time between November 1st, 2011 and August 30th, 2012 For PRO
  • Sub-sample:
  • ability to read and write since they will be asked to participate in the PRO part of the study.
  • Selection will not be based on the disease stage of each patient, in order to avoid a selection bias.

Exclusion criteria

  • According to the study design there will not be any exclusion criteria in order to provide a high validity and to obtain the most accurate real daily practice information.

Treatment and study plan

Primary outcomes

  1. Use of health resources by collecting data about hospital description and characteristics, Disease Diagnosis Procedures and Therapy information

    Time frame: April 2014(26 Months)

Secondary outcomes

  1. Patient-Reported Outcomes (PRO) through self-administered questionnaires and the patients will be asked to complete them at each evaluation visit(25% of the whole sample)

    Time frame: April 2014(26 Months)

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Epidemiological Study to Describe NSCLC Clinical Management Patterns in MENA

Acronym: Lung-EPICLIN/G

Important dates

Study start
2012
Primary completion
2015
Study completion
2015
First posted
Mar 26, 2012
Registry last updated
May 24, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.